What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients? [1]

Journal of Clinical Oncology

Volumn 25, Issue 9, 2007, Pages 1140-1141

  Quaglino, Pietro ^a   Osella Abate, Simona ^a   Savoia, Paola ^a   Bernengo, Maria Grazia ^a   Cappello, Nazario ^b   Cavallo, Franco ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MONOPHENOL MONOOXYGENASE; MAGEA3 PROTEIN, HUMAN; MART1 ANTIGEN; MELANOCYTE LINEAGE SPECIFIC ANTIGEN GP100; MELANOCYTE LINEAGE-SPECIFIC ANTIGEN GP100; MEMBRANE PROTEIN; RNA; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG;

CANCER CLASSIFICATION; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; FOLLOW UP; HUMAN; LETTER; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BLOOD; GENETICS; LYMPH NODE; NOTE; PATHOLOGY; SKIN TUMOR; SURVIVAL;

ANTIGENS, NEOPLASM; HUMANS; LYMPH NODES; MELANOMA; MEMBRANE GLYCOPROTEINS; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34047211570     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.09.1538     Document Type: Letter

References (6)

1. Scoggins CR, Ross MI, Reitgen DS, et al: Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma. J Clin Oncol 24:2849-2857, 2006
2. Schmidt H, Sorensen BS, Sjoegren P, et al: Circulating tyrosinase and MART-1 mRNA does not independently predict relapse or survival in patients with AJCC stage I-II melanoma. J Invest Dermatol 126:849-854, 2006
3. Quaglino P, Savoia P, Osella-Abate S, et al: RT-PCR tyrosinase expression in the peripheral blood of melanoma patients: From research bench to clinical practice. Expert Rev Mol Diagn 4:727-741, 2004
4. Palmieri G, Ascierto PA, Perrone F, et al: Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction. J Clin Oncol 21:767-773, 2003
5. Osella-Abate S, Savoia P, Quaglino P, et al: Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: A clinical follow-up study of 110 patients. Br J Cancer 89:1457-1462, 2003
6. Voit C, Kron M, Rademaker J, et al: Molecular staging in stage II and III melanoma patients and its effect on long-term survival. J Clin Oncol 23:1218-1227, 2005